Literature DB >> 33771080

Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City.

Rosa Gabriela Hernández-Cruz1, Daniela Sánchez-Cobo1, Sandra Acevedo-Gallegos1, Addy Cecilia Helguera-Repetto1, Mario Roberto Rodriguez-Bosch1, Victor Hugo Ramirez-Santes1, Isabel Villegas-Mota1, Arturo Cardona-Pérez1, Manuel Cortes-Bonilla1, Claudine Irles1, Paloma Mateu-Rogell1, Job Villanueva-Calleja1, Oscar Villavicencio Carrisoza1, Gaudalupe Estrada-Gutiérrez1, Salvador Espino-Y-Sosa1, Johnatan Torres-Torres1,2, Raigam Jafet Martinez-Portilla1,2.   

Abstract

BACKGROUND: COVID-19 symptoms vary widely among pregnant women. We aimed to assess the most frequent symptoms amongst pregnant women with SARS-CoV-2 infection in a tertiary hospital in Mexico City.
METHODS: A cross-sectional study of pregnant women attending the National Institute of Perinatology in Mexico City was performed. All women who attended the hospital, despite their symptoms, were tested for SARS-CoV-2. A multivariate-age-adjusted logistic regression was used to assess the association between the main outcome and each characteristic of the clinical history.
RESULTS: A total of 1880 women were included in the data analysis. Among all women, 30.74% (n = 578) had a positive PCR for SARS-CoV-2 from which 2.7 (n = 50) were symptomatic. Symptoms associated with a positive PCR result were headache (p=.01), dyspnea (p=.043), and myalgia (p=.043).
CONCLUSIONS: At universal screening for SARS-CoV-2, one-third of the population had a positive result, while those symptoms associated with a positive PCR were headache, dyspnea, and myalgia.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus 2019; pregnancy; universal screening

Year:  2021        PMID: 33771080     DOI: 10.1080/14767058.2021.1902500

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  4 in total

Review 1.  Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Authors:  Thomas Struyf; Jonathan J Deeks; Jacqueline Dinnes; Yemisi Takwoingi; Clare Davenport; Mariska Mg Leeflang; René Spijker; Lotty Hooft; Devy Emperador; Julie Domen; Anouk Tans; Stéphanie Janssens; Dakshitha Wickramasinghe; Viktor Lannoy; Sebastiaan R A Horn; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2022-05-20

2.  Cord Blood SARS-CoV-2 IgG Antibodies and Their Association With Maternal Immunity and Neonatal Outcomes.

Authors:  Addy Cecilia Helguera-Repetto; Isabel Villegas-Mota; Guadalupe Itzel Arredondo-Pulido; Jorge Arturo Cardona-Pérez; Moises León-Juárez; Maria Antonieta Rivera-Rueda; Gabriela Arreola-Ramírez; Paloma Mateu-Rogell; Sandra Acevedo-Gallegos; Gloria Elena López-Navarrete; María Yolotzin Valdespino-Vázquez; Guadalupe Martínez-Salazar; Mario Rodríguez-Bosch; Irma Alejandra Coronado-Zarco; María Del Rosario Castillo-Gutiérrez; Carlos Alberto Cuevas-Jiménez; Elsa Romelia Moreno-Verduzco; Salvador Espino-Y-Sosa; Manuel Cortés-Bonilla; Claudine Irles
Journal:  Front Pediatr       Date:  2022-06-29       Impact factor: 3.569

3.  Impact of COVID-19 on pregnant women in South Korea: Focusing on prevalence, severity, and clinical outcomes.

Authors:  So Hee Kim; Yeonmi Choi; Dokyoung Lee; Hyejin Lee; Ji Hoi Kim; Eun Saem Choi; Young Mi Jung; Jinwoo Lee; Pyoeng Gyun Choe; Ji Yoon Lee; Youngme Do; Chan-Wook Park; Joong Shin Park; Jong Kwan Jun; Seung Mi Lee; Jin Yong Lee
Journal:  J Infect Public Health       Date:  2022-01-17       Impact factor: 3.718

4.  Evidence of possible SARS-CoV-2 vertical transmission according to World Health Organization criteria in asymptomatic pregnant women.

Authors:  R Sevilla-Montoya; A Hidalgo-Bravo; G Estrada-Gutiérrez; O Villavicencio-Carrisoza; M Leon-Juarez; I Villegas-Mota; S Espino-Y-Sosa; I E Monroy-Muñoz; R J Martinez-Portilla; L C Poon; J A Cardona-Pérez; A C Helguera-Repetto
Journal:  Ultrasound Obstet Gynecol       Date:  2021-12       Impact factor: 7.299

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.